Skip to main content

Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.

Publication ,  Journal Article
Murdoch, DR; Reller, LB
Published in: Antimicrob Agents Chemother
December 2001

Antimicrobial susceptibility testing of 192 group B streptococcal isolates from patients with invasive disease demonstrated that 31 (16%) were resistant to erythromycin and 17 (9%) were resistant to clindamycin. One isolate demonstrated high-level resistance to streptomycin, but none was highly resistant to gentamicin. Erythromycin and clindamycin are no longer reliable empirical alternatives to penicillin for the treatment and prevention of group B streptococcal infections.

Duke Scholars

Published In

Antimicrob Agents Chemother

DOI

ISSN

0066-4804

Publication Date

December 2001

Volume

45

Issue

12

Start / End Page

3623 / 3624

Location

United States

Related Subject Headings

  • Streptococcus agalactiae
  • Streptococcal Infections
  • Pregnancy
  • Microbiology
  • Microbial Sensitivity Tests
  • Macrolides
  • Infant, Newborn
  • Humans
  • Female
  • Drug Resistance, Microbial
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Murdoch, D. R., & Reller, L. B. (2001). Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob Agents Chemother, 45(12), 3623–3624. https://doi.org/10.1128/AAC.45.12.3623-3624.2001
Murdoch, D. R., and L. B. Reller. “Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.Antimicrob Agents Chemother 45, no. 12 (December 2001): 3623–24. https://doi.org/10.1128/AAC.45.12.3623-3624.2001.
Murdoch, D. R., and L. B. Reller. “Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.Antimicrob Agents Chemother, vol. 45, no. 12, Dec. 2001, pp. 3623–24. Pubmed, doi:10.1128/AAC.45.12.3623-3624.2001.
Murdoch DR, Reller LB. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob Agents Chemother. 2001 Dec;45(12):3623–3624.

Published In

Antimicrob Agents Chemother

DOI

ISSN

0066-4804

Publication Date

December 2001

Volume

45

Issue

12

Start / End Page

3623 / 3624

Location

United States

Related Subject Headings

  • Streptococcus agalactiae
  • Streptococcal Infections
  • Pregnancy
  • Microbiology
  • Microbial Sensitivity Tests
  • Macrolides
  • Infant, Newborn
  • Humans
  • Female
  • Drug Resistance, Microbial